Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,826.00p

Buy

1,827.00p

arrow-down-11.00p (-0.60%)

Prices updated at 12 Nov 2024, 16:39 GMT

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

-1.25%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

07 Nov 2024

24 Oct 2024

01 Oct 2024

24 Sep 2024

10 Sep 2024

13 Aug 2024

08 Aug 2024

29 Jul 2024

15 Jul 2024

Key dates

	Forecast date
Half yearly results	Aug 2025
Annual general meeting	Apr 2025
Annual report	Mar 2025
Final results	Feb 2025

	Previous date
Half yearly results	Aug 2024
Annual general meeting	Apr 2024
Annual report	Mar 2024
Final results	Feb 2024

Company reports

31 Dec 2023

Annual Report

31 Dec 2023

Quarterly Report

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.